DR, P., EP, J., KA, F., & IF, P. (2013). Survivin inhibitor YM-155 sensitizes tumor necrosis factor- related apoptosis-inducing ligand-resistant glioma cells to apoptosis through Mcl-1 downregulation and by engaging the mitochondrial death pathway. The Journal of pharmacology and experimental therapeutics, 346(2), 201. https://doi.org/10.1124/jpet.113.204743
Chicago Style (17th ed.) CitationDR, Premkumar, Jane EP, Foster KA, and Pollack IF. "Survivin Inhibitor YM-155 Sensitizes Tumor Necrosis Factor- Related Apoptosis-inducing Ligand-resistant Glioma Cells to Apoptosis Through Mcl-1 Downregulation and by Engaging the Mitochondrial Death Pathway." The Journal of Pharmacology and Experimental Therapeutics 346, no. 2 (2013): 201. https://doi.org/10.1124/jpet.113.204743.
MLA (9th ed.) CitationDR, Premkumar, et al. "Survivin Inhibitor YM-155 Sensitizes Tumor Necrosis Factor- Related Apoptosis-inducing Ligand-resistant Glioma Cells to Apoptosis Through Mcl-1 Downregulation and by Engaging the Mitochondrial Death Pathway." The Journal of Pharmacology and Experimental Therapeutics, vol. 346, no. 2, 2013, p. 201, https://doi.org/10.1124/jpet.113.204743.